Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of CONCORD DRUGS. For more details, see the CONCORD DRUGS quarterly results and CONCORD DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.7 |
No. of shares | m | 10.00 |
1 Week | % | 0.2 |
1 Month | % | 6.2 |
1 Year | % | 24.6 |
52 week H/L | Rs | 61.5/25.6 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
CONCORD DRUGS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 34 | 24 | 33 | 45 | 42 | |
Low | Rs | 15 | 12 | 13 | 25 | 20 | |
Sales per share (Unadj.) | Rs | 61.2 | 58.7 | 58.8 | 67.5 | 55.9 | |
Earnings per share (Unadj.) | Rs | 0.5 | 0.4 | 3.8 | 1.8 | 1.1 | |
Diluted earnings per share | Rs | 0.4 | 0.3 | 3.3 | 1.6 | 1.0 | |
Cash flow per share (Unadj.) | Rs | 2.7 | 2.1 | 5.3 | 3.8 | 2.8 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 29.5 | 26.9 | 30.6 | 32.4 | 33.4 | |
Adj. book value per share | Rs | 23.2 | 23.5 | 26.8 | 28.4 | 31.1 | |
Shares outstanding (eoy) | m | 7.86 | 8.74 | 8.74 | 8.74 | 9.32 | |
Price / Sales ratio | x | 0.4 | 0.3 | 0.4 | 0.5 | 0.5 | |
Avg P/E ratio | x | 47.0 | 46.9 | 6.1 | 19.1 | 28.9 | |
P/CF ratio (eoy) | x | 9.0 | 8.6 | 4.3 | 9.1 | 10.9 | |
Price / Book Value ratio | x | 0.8 | 0.7 | 0.7 | 1.1 | 0.9 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 191 | 154 | 201 | 305 | 285 | |
Total wages/salary | Rs m | 23 | 33 | 35 | 41 | 38 |
CONCORD DRUGS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 481 | 513 | 514 | 590 | 521 | |
Other income | Rs m | 1 | 1 | 1 | 1 | 0 | |
Total revenues | Rs m | 482 | 515 | 515 | 591 | 521 | |
Gross profit | Rs m | 37 | 33 | 70 | 56 | 46 | |
Depreciation | Rs m | 17 | 15 | 14 | 18 | 16 | |
Interest | Rs m | 16 | 15 | 14 | 17 | 17 | |
Profit before tax | Rs m | 4 | 5 | 43 | 22 | 12 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 1 | 10 | 7 | 3 | |
Profit after tax | Rs m | 4 | 3 | 33 | 16 | 10 | |
Gross profit margin | % | 7.6 | 6.5 | 13.6 | 9.5 | 8.8 | |
Effective tax rate | % | 7.5 | 28.1 | 23.5 | 29.1 | 21.1 | |
Net profit margin | % | 0.8 | 0.6 | 6.4 | 2.7 | 1.9 |
CONCORD DRUGS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 697 | 456 | 360 | 419 | 435 | |
Current liabilities | Rs m | 561 | 272 | 162 | 236 | 216 | |
Net working cap to sales | % | 28.4 | 35.8 | 38.5 | 30.9 | 41.9 | |
Current ratio | x | 1.2 | 1.7 | 2.2 | 1.8 | 2.0 | |
Inventory Days | Days | 7 | 7 | 0 | 0 | 7 | |
Debtors Days | Days | 3,677 | 1,809 | 147,316,559 | 1,415 | 1,108 | |
Net fixed assets | Rs m | 130 | 125 | 139 | 146 | 148 | |
Share capital | Rs m | 79 | 87 | 87 | 87 | 93 | |
"Free" reserves | Rs m | 153 | 147 | 180 | 196 | 218 | |
Net worth | Rs m | 232 | 235 | 268 | 284 | 311 | |
Long term debt | Rs m | 7 | 9 | 38 | 17 | 19 | |
Total assets | Rs m | 828 | 580 | 499 | 564 | 582 | |
Interest coverage | x | 1.3 | 1.3 | 4.0 | 2.3 | 1.7 | |
Debt to equity ratio | x | 0 | 0 | 0.1 | 0.1 | 0.1 | |
Sales to assets ratio | x | 0.6 | 0.9 | 1.0 | 1.0 | 0.9 | |
Return on assets | % | 2.4 | 3.2 | 9.4 | 5.8 | 4.6 | |
Return on equity | % | 1.8 | 1.4 | 12.3 | 5.6 | 3.2 | |
Return on capital | % | 8.5 | 8.2 | 18.7 | 13.1 | 8.9 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
CONCORD DRUGS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 12 | 25 | 16 | 8 | 17 | |
From Investments | Rs m | -3 | -8 | -37 | -24 | -23 | |
From Financial Activity | Rs m | -7 | -18 | 21 | 17 | 6 | |
Net Cashflow | Rs m | 1 | -1 | 0 | 0 | 0 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: S Nagi Reddy | COMP SEC: Ankur Bisht | YEAR OF INC: 1995 | BSE CODE: 538965 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare CONCORD DRUGS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.